Inotiv, inc. announces proposed convertible senior notes offering

West lafayette, ind., sept. 21, 2021 (globe newswire) -- inotiv, inc. (nasdaq: notv) (the “company”, “we”, “our” or “inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today announced its intention to offer, subject to market and other conditions, $110,000,000 aggregate principal amount of convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the “securities act”). the notes will be fully and unconditionally guaranteed, on a senior, unsecured basis, by bas evansville, inc., a wholly owned subsidiary of inotiv (the “guarantor”). inotiv also expects to grant the initial purchaser of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $16,500,000 principal amount of notes.
NOTV Ratings Summary
NOTV Quant Ranking